首页> 外文OA文献 >Comparison of gabapentin and ketotifen in treatment of uremic pruritus in hemodialysis patients
【2h】

Comparison of gabapentin and ketotifen in treatment of uremic pruritus in hemodialysis patients

机译:加巴喷丁和酮替芬治疗血液透析患者尿毒症瘙痒的比较

摘要

Objectives: Uremic pruritus is a common problem in hemodialysis patients. Several treatments have been used for decreasing itching in these patients. Gabapentin and ketotifen are two drugs used for treating uremic patients.The aim of this study was to compare gabapentin and ketotifen in treatment of uremic pruritus in hemodialysis patients. Methods: In this double-blind randomized clinical trial, 52 hemodialysis patients with uremic pruritus referred to 5azarTeaching Hospital in Gorgan in 2013 were studied. Patients were randomly assigned to two groups of 26 subjects (groups G and K). In group G, patients treated with gabapentin capsules 100 mg daily for 2 weeks, and in Group K, patients treated with ketotifen 1 mg twice daily for 2 weeks. Before and at the end of study, pruritus severity was determined based on Shiratori›s severity scores. Collected data were analyzed by SPSS-21 statistical software. Results: There was no significant different between two groups in the age and sex. After two weeks of treatment, severity of pruritus was significantly reduced in both groups (88.4 in group G vs. 76.9 in group K). Gabapentin compared with ketotifen had a better effect on improving itching in the age group of 30-60 years and in males. 5 patients (19.2) in both groups suffered from drowsiness and dizziness, but no serious side effects were observed. Conclusions: The results showed that gabapentin and ketotifen significantly improved pruritus in hemodialysis patients, and no significant difference was observed between two groups. © 2016, Professional Medical Publications. All rights reserved.
机译:目的:尿毒症瘙痒症是血液透析患者的常见问题。已经使用了几种疗法来减轻这些患者的瘙痒。加巴喷丁和酮替芬是用于治疗尿毒症患者的两种药物。本研究的目的是比较加巴喷丁和酮替芬在血液透析患者中​​治疗尿毒症瘙痒的疗效。方法:在这项双盲随机临床试验中,研究了2013年转诊至Gorgan 5azarTeaching医院的52例尿毒症瘙痒的血液透析患者。将患者随机分为两组,每组26名受试者(G组和K组)。在G组中,患者接受加巴喷丁胶囊100 mg每天治疗2周,在K组中,患者接受酮替芬1 mg每天两次两次治疗2周。在研究之前和研究结束时,根据白鸟的严重程度评分确定瘙痒严重程度。收集的数据通过SPSS-21统计软件进行分析。结果:两组在年龄和性别上无显着差异。治疗两周后,两组的瘙痒严重程度均显着降低(G组为88.4,K组为76.9)。加巴喷丁与酮替芬相比,在30-60岁年龄段和男性中改善瘙痒效果更好。两组中有5例(19.2)出现嗜睡和头晕,但未观察到严重的副作用。结论:结果显示加巴喷丁和酮替芬可显着改善血液透析患者的瘙痒,两组之间无显着差异。 ©2016,专业医学出版物。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号